T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, remain a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback